Millennium Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-272,584
| Closed | -$23.6K | – | 6833 |
|
|
2023
Q3 | $23.6K | Buy |
272,584
+249,043
| +1,058% | +$71.8K | ﹤0.01% | 5613 |
|
|
2023
Q2 | $13.2K | Sell |
23,541
-136,870
| -85% | -$121K | ﹤0.01% | 5712 |
|
|
2023
Q1 | $183K | Sell |
160,411
-13,536
| -8% | -$16.2K | ﹤0.01% | 5208 |
|
|
2022
Q4 | $195K | Buy |
173,947
+11,719
| +7% | +$18.7K | ﹤0.01% | 5348 |
|
|
2022
Q3 | $341K | Buy |
162,228
+114,103
| +237% | +$222K | ﹤0.01% | 5266 |
|
|
2022
Q2 | $65K | Buy |
+48,125
| New | +$69.7K | ﹤0.01% | 6092 |
|
|
2022
Q1 | – | Sell |
-43,560
| Closed | -$47K | – | 7762 |
|
|
2021
Q4 | $47K | Sell |
43,560
-84,003
| -66% | -$136K | ﹤0.01% | 6492 |
|
|
2021
Q3 | $376K | Sell |
127,563
-32,577
| -20% | -$110K | ﹤0.01% | 5623 |
|
|
2021
Q2 | $482K | Buy |
+160,140
| New | +$490K | ﹤0.01% | 5341 |
|
|
2020
Q2 | – | Sell |
-418,646
| Closed | -$1.33M | – | 4735 |
|
|
2020
Q1 | $1.33M | Buy |
+418,646
| New | +$2.23M | ﹤0.01% | 2287 |
|
|
2019
Q4 | – | Sell |
-70,224
| Closed | -$269K | – | 4741 |
|
|
2019
Q3 | $269K | Sell |
70,224
-47,149
| -40% | -$160K | ﹤0.01% | 3620 |
|
|
2019
Q2 | $446K | Sell |
117,373
-124,742
| -52% | -$415K | ﹤0.01% | 3315 |
|
|
2019
Q1 | $872K | Sell |
242,115
-89,217
| -27% | -$657K | ﹤0.01% | 2944 |
|
|
2018
Q4 | $2.57M | Buy |
+331,332
| New | +$2.65M | ﹤0.01% | 2042 |
|
Other funds holding RVLP
Millennium Management's RVLP Position: Q4 2023 in Review
Millennium Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 272,584 shares — an estimated $23.6K sold.
Millennium Management first reported a position in RVLP in Q4 2018 and held it in 14 quarters. The position peaked at $2.57M in Q4 2018. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.
- Millennium Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Millennium Management sold 272,584 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $23.6K.
- Millennium Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 14 quarters.
- Millennium Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $2.57M in Q4 2018.
- 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.